Back

Transcatheter aortic valve implantation in large annuli: incidence and predictors of specific adverse events with the largest self-expanding device

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Structural percutaneous intervention Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Verena Veulemans

University Hospital Duesseldorf, Duesseldorf (Germany)

8 More presentations in this session

Presentation thumbnail
Incidence of bicuspid aortic valve in 16,185 neonates by echocardiographic screening in a single institution: is it really congenial?
Doctor K. Waki (Kurashiki, JP)
Abstract Slides
Presentation thumbnail
Predictors of access site complication in transfemoral transcatheter aortic valve implantation
Doctor M. Potratz (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.
Associate Professor G. Tarantini (Padova, IT)
Abstract
Presentation thumbnail
Clinical outcomes after early vs new generation TAVR device deployment
Doctor L. Kalinczuk (Warsaw, PL)
Abstract
Presentation thumbnail
Differences in short-term outcome between balloon- and self-expandable TAVR devices relating to more than one generation.
Professor V. Veulemans (Duesseldorf, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Structural percutaneous intervention

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources